158 related articles for article (PubMed ID: 17255781)
1. Sarcomatoid breast tumors have sarcomatoid behavior.
Gilcrease MZ
Am J Surg Pathol; 2007 Feb; 31(2):326-7; author reply 327. PubMed ID: 17255781
[No Abstract] [Full Text] [Related]
2. [Micrometastases of the axillary lymph nodes in breast cancer. An immunohistochemical study].
Ronay G; Tomesch A; Tulusan AH
Pathologe; 1989 Sep; 10(5):289-93. PubMed ID: 2477837
[No Abstract] [Full Text] [Related]
3. Expression of cytokeratin markers, ER-alpha, PR, HER-2/neu, and EGFR in pure ductal carcinoma in situ (DCIS) and DCIS with co-existing invasive ductal carcinoma (IDC) of the breast.
Steinman S; Wang J; Bourne P; Yang Q; Tang P
Ann Clin Lab Sci; 2007; 37(2):127-34. PubMed ID: 17522367
[TBL] [Abstract][Full Text] [Related]
4. Basal-like subtype breast cancers in women older than 40 years of age.
Erşahin C; Chivukula M; Bhargava R; Dabbs DJ
Int J Surg Pathol; 2010 Feb; 18(1):42-7. PubMed ID: 19372082
[TBL] [Abstract][Full Text] [Related]
5. Unifocal intranodal Langerhans' cell histiocytosis associated with metastatic breast carcinoma.
Cina SJ; Askin FB
Arch Pathol Lab Med; 1996 Dec; 120(12):1085. PubMed ID: 15456171
[No Abstract] [Full Text] [Related]
6. [Evaluation of sentinel lymph node biopsy in detection of axillary lymph node metastasis in breast cancer].
Zhang JG; Zhong L; Li CL
Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):235-6. PubMed ID: 17649646
[No Abstract] [Full Text] [Related]
7. Minichromosome maintenance protein 2 is a reliable proliferative marker in breast carcinoma.
Reena RM; Mastura M; Siti-Aishah MA; Munirah MA; Norlia A; Naqiyah I; Rohaizak M; Sharifah NA
Ann Diagn Pathol; 2008 Oct; 12(5):340-3. PubMed ID: 18774496
[TBL] [Abstract][Full Text] [Related]
8. [Lymph node metastasis of a "squamous cell carcinoma" as a manifestation of occult breast cancer].
Ronay G; Zimmermann HD; Tulusan AH
Pathologe; 1988 Sep; 9(5):309-12. PubMed ID: 2845387
[No Abstract] [Full Text] [Related]
9. [Expression and prognostic value of transcriptional factor sp1 in breast cancer].
Wang XB; Peng WQ; Yi ZJ; Zhu SL; Gan QH
Ai Zheng; 2007 Sep; 26(9):996-1000. PubMed ID: 17927860
[TBL] [Abstract][Full Text] [Related]
10. CD44 expression and axillary lymph node metastasis in infiltrating ductal carcinoma of the breast.
Looi LM; Cheah PL; Zhao W; Ng MH; Yip CH
Malays J Pathol; 2006 Dec; 28(2):83-6. PubMed ID: 18376796
[TBL] [Abstract][Full Text] [Related]
11. FOXA1 expression in breast cancer--correlation with luminal subtype A and survival.
Badve S; Turbin D; Thorat MA; Morimiya A; Nielsen TO; Perou CM; Dunn S; Huntsman DG; Nakshatri H
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4415-21. PubMed ID: 17671124
[TBL] [Abstract][Full Text] [Related]
12. The presence of alveolar structures in invasive ductal NOS breast carcinoma is associated with lymph node metastasis.
Zavyalova MV; Perelmuter VM; Vtorushin SV; Denisov EV; Litvyakov NV; Slonimskaya EM; Cherdyntseva NV
Diagn Cytopathol; 2013 Mar; 41(3):279-82. PubMed ID: 22102485
[No Abstract] [Full Text] [Related]
13. Is breast tumor progression really linear?
Polyak K
Clin Cancer Res; 2008 Jan; 14(2):339-41. PubMed ID: 18223205
[No Abstract] [Full Text] [Related]
14. Bone metastasis is strongly associated with estrogen receptor-positive/progesterone receptor-negative breast carcinomas.
Wei B; Wang J; Bourne P; Yang Q; Hicks D; Bu H; Tang P
Hum Pathol; 2008 Dec; 39(12):1809-15. PubMed ID: 18715613
[TBL] [Abstract][Full Text] [Related]
15. Comparison of two score systems in Bcl-2 and Bax protein expression in invasive ductal carcinoma of breast and relation with oestrogen and progestrone receptors.
Ayatollahi H; Ghaffarzadegan K; Sharifi N; Farahmand MJ; Jarafian AH
Breast J; 2009; 15(3):310-2. PubMed ID: 19645793
[No Abstract] [Full Text] [Related]
16. Metastatic mammary carcinoma with DCIS-like morphology: a report of two cases.
Coyne J
Int J Surg Pathol; 2012 Oct; 20(5):485-7. PubMed ID: 22297833
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of interleukin-10 in sentinel lymph node with breast cancer.
Woo SU; Bae JW; Yang JH; Kim JH; Nam SJ; Shin YK
Ann Surg Oncol; 2007 Nov; 14(11):3268-73. PubMed ID: 17762971
[TBL] [Abstract][Full Text] [Related]
18. BP1, a putative signature marker for inflammatory breast cancer and tumor aggressiveness.
Man YG; Schwartz A; Levine PH; Teal C; Berg PE
Cancer Biomark; 2009; 5(1):9-17. PubMed ID: 19242057
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemistry to detect sentinel nodal metastases in mammary lobular carcinoma.
Cserni G
Hum Pathol; 2009 Mar; 40(3):441; author reply 442. PubMed ID: 19200488
[No Abstract] [Full Text] [Related]
20. [Lymphoreticular infiltrates in axillary lymph node metastases of invasive ductal breast cancers: histological and immunohistological findings].
Horny HP; Horst HA
Verh Dtsch Ges Pathol; 1985; 69():331-7. PubMed ID: 3006384
[No Abstract] [Full Text] [Related]
[Next] [New Search]
